Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Industry News
Search Articles:
Alnylam initiates ILLUMINATE-B phase 3 pediatric study of lumasiran for treatment of PH1
Alnylam Pharmaceuticals announced it has initiated ILLUMINATE-B, a global Phase 3 pediatric study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic in development for treatment of primary hyperoxaluria type 1.
April 15, 2019
More...
Email This Page
to a Friend
Print This
Page